UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 393

Sortiert nach

Personal Protective Equipment: Protecting Health Care Providers in an Ebola Outbreak

Clinical therapeutics, 2015-11, Vol.37 (11), p.2402-2410

2015

Volltextzugriff (PDF)

Confronting Ebola as a Sexually Transmitted Infection

Clinical infectious diseases, 2016-05, Vol.62 (10), p.1272-1276

2016

Volltextzugriff (PDF)

Antiviral and clinical activity of bamlanivimab in a randomized trial of non-hospitalized adults with COVID-19

Nature communications, 2022-08, Vol.13 (1), p.4931-4931, Article 4931

2022

Volltextzugriff (PDF)

COVID-19 symptoms at time of testing and association with positivity among outpatients tested for SARS-CoV-2

PloS one, 2021-12, Vol.16 (12), p.e0260879-e0260879

2021

Volltextzugriff (PDF)

Evaluation of a COVID-19 convalescent plasma program at a U.S. academic medical center

PloS one, 2022-12, Vol.17 (12), p.e0277707-e0277707

2022

Volltextzugriff (PDF)

Modeling the emergence of viral resistance for SARS-CoV-2 during treatment with an anti-spike monoclonal antibody

PLoS pathogens, 2024-04, Vol.20 (4), p.e1011680

2024

Volltextzugriff (PDF)

All-Cause and Cause-Specific Mortality Among Black and White North Carolina State Prisoners, 1995–2005

Annals of epidemiology, 2011-10, Vol.21 (10), p.719-726

2011

Volltextzugriff (PDF)

Publisher Correction: Antiviral and clinical activity of bamlanivimab in a randomized trial of non-hospitalized adults with COVID-19

Nature communications, 2023-01, Vol.14 (1), p.333-333, Article 333

2023

Volltextzugriff (PDF)

Protecting healthcare personnel from acquiring Ebola virus disease

Infection control and hospital epidemiology, 2015-10, Vol.36 (10), p.1229-1232

2015

Volltextzugriff (PDF)

The prevalence of Post-Ebola Syndrome hearing loss, Sierra Leone

BMC infectious diseases, 2022-07, Vol.22 (1), p.624-624, Article 624

2022

Volltextzugriff (PDF)

Remdesivir Treatment in Hospitalized Patients With Coronavirus Disease 2019 (COVID-19): A Comparative Analysis of In-hospital All-cause Mortality in a Large Multicenter Observational Cohort

Clinical infectious diseases, 2022-08, Vol.75 (1), p.e450-e458

2022

Volltextzugriff (PDF)

Antiviral Activity, Pharmacokinetics, and Safety of BMS-488043, a Novel Oral Small-Molecule HIV-1 Attachment Inhibitor, in HIV-1-Infected Subjects

Antimicrobial Agents and Chemotherapy, 2011-02, Vol.55 (2), p.722-728

2011

Volltextzugriff (PDF)

Simplification to abacavir/lamivudine + atazanavir maintains viral suppression and improves bone and renal biomarkers in ASSURE, a randomized, open label, non-inferiority trial

PloS one, 2014-05, Vol.9 (5), p.e96187

2014

Volltextzugriff (PDF)

COVID-19 therapies for inpatients: a review and quality assessment of clinical guidelines

ERJ open research, 2022-10, Vol.8 (4), p.236

2022

Volltextzugriff (PDF)

Change in vitamin D levels and risk of severe vitamin D deficiency over 48 weeks among HIV-1-infected, treatment-naive adults receiving rilpivirine or efavirenz in a Phase III trial (ECHO)

Antiviral therapy, 2014-01, Vol.19 (2), p.191-200

2014

Volltextzugriff (PDF)

Ezetimibe Alone Reduces Low-Density Lipoprotein Cholesterol in HIV-Infected Patients Receiving Combination Antiretroviral Therapy

Clinical infectious diseases, 2008-10, Vol.47 (8), p.1105-1108

2008

Volltextzugriff (PDF)

A phase 2a clinical trial of molnupiravir in patients with COVID-19 shows accelerated SARS-CoV-2 RNA clearance and elimination of infectious virus

Science translational medicine, 2022-01, Vol.14 (628), p.eabl7430

2022

Volltextzugriff (PDF)

Randomized Study of the Safety and Efficacy of Fish Oil (Omega-3 Fatty Acid) Supplementation with Dietary and Exercise Counseling for the Treatment of Antiretroviral Therapy—Associated Hypertriglyceridemia

Clinical infectious diseases, 2005-11, Vol.41 (10), p.1498-1504

2005

Volltextzugriff (PDF)

Inequities in access to diagnostics threatens global public health security

The Lancet infectious diseases, 2022-06, Vol.22 (6), p.754-756

2022

Volltextzugriff (PDF)

Best practices for identifying men who have sex with men for corrections-based pre-exposure prophylaxis provision

Health & justice, 2019-04, Vol.7 (1), p.7-4, Article 7

2019

Volltextzugriff (PDF)

Combining vaccines, optimised supportive care, and therapeutics for Ebola virus disease increases survival

The Lancet infectious diseases, 2024-06, Vol.24 (6), p.560-562

2024

Volltextzugriff (PDF)

It takes more than a machine: A pilot feasibility study of point-of-care HIV-1 viral load testing at a lower-level health center in rural western Uganda

PLOS global public health, 2023, Vol.3 (3), p.e0001678-e0001678

2023

Volltextzugriff (PDF)

Bamlanivimab therapy for acute COVID-19 does not blunt SARS-CoV-2-specific memory T cell responses

JCI insight, 2022-12, Vol.7 (24)

2022

Volltextzugriff (PDF)

Does HAART efficacy translate to effectiveness? Evidence for a trial effect

PloS one, 2011-07, Vol.6 (7), p.e21824-e21824

2011

Volltextzugriff (PDF)

1 – 25 von 393

Suche als RSS-Feed

Aktive Filter

Nur zeigenGeprüft (Peer-Review)

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Mit Volltextzugriff
(323)

Publikationsform

Artikel
(386)
Reviews
(7)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(295)
Life Sciences & Biomedicine
(263)
Humans
(213)
Infectious Diseases
(154)
Male
(137)
Female
(127)
Adult
(118)
Hiv
(110)
Human Immunodeficiency Virus
(101)
Immunology
(92)
Middle Aged
(80)
Hiv Infections - Drug Therapy
(78)
Biological And Medical Sciences
(59)
Medical Sciences
(57)
Microbiology
(56)
Public, Environmental & Occupational Health
(51)
Viral Diseases
(49)
Aids/hiv
(47)
Covid-19
(41)
Public Health
(39)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(4)
... seit 90 Tagen
(9)

Menü

Weitere Dienste

Einstellungen

Switching from tenofovir disoproxil fumarate to tenofovir alafenamide in antiretroviral regimens for virologically suppressed adults with HIV-1 infection: a randomised, active-controlled, multicentre, open-label, phase 3, non-inferiority study

Personal Protective Equipment: Protecting Health Care Providers in an Ebola Outbreak

Confronting Ebola as a Sexually Transmitted Infection

Antiviral and clinical activity of bamlanivimab in a randomized trial of non-hospitalized adults with COVID-19

COVID-19 symptoms at time of testing and association with positivity among outpatients tested for SARS-CoV-2

Evaluation of a COVID-19 convalescent plasma program at a U.S. academic medical center

Modeling the emergence of viral resistance for SARS-CoV-2 during treatment with an anti-spike monoclonal antibody

All-Cause and Cause-Specific Mortality Among Black and White North Carolina State Prisoners, 1995–2005

Publisher Correction: Antiviral and clinical activity of bamlanivimab in a randomized trial of non-hospitalized adults with COVID-19

Protecting healthcare personnel from acquiring Ebola virus disease

The prevalence of Post-Ebola Syndrome hearing loss, Sierra Leone

Remdesivir Treatment in Hospitalized Patients With Coronavirus Disease 2019 (COVID-19): A Comparative Analysis of In-hospital All-cause Mortality in a Large Multicenter Observational Cohort

Antiviral Activity, Pharmacokinetics, and Safety of BMS-488043, a Novel Oral Small-Molecule HIV-1 Attachment Inhibitor, in HIV-1-Infected Subjects

Simplification to abacavir/lamivudine + atazanavir maintains viral suppression and improves bone and renal biomarkers in ASSURE, a randomized, open label, non-inferiority trial

COVID-19 therapies for inpatients: a review and quality assessment of clinical guidelines

Change in vitamin D levels and risk of severe vitamin D deficiency over 48 weeks among HIV-1-infected, treatment-naive adults receiving rilpivirine or efavirenz in a Phase III trial (ECHO)

Ezetimibe Alone Reduces Low-Density Lipoprotein Cholesterol in HIV-Infected Patients Receiving Combination Antiretroviral Therapy

A phase 2a clinical trial of molnupiravir in patients with COVID-19 shows accelerated SARS-CoV-2 RNA clearance and elimination of infectious virus

Randomized Study of the Safety and Efficacy of Fish Oil (Omega-3 Fatty Acid) Supplementation with Dietary and Exercise Counseling for the Treatment of Antiretroviral Therapy—Associated Hypertriglyceridemia

Inequities in access to diagnostics threatens global public health security

Best practices for identifying men who have sex with men for corrections-based pre-exposure prophylaxis provision

Combining vaccines, optimised supportive care, and therapeutics for Ebola virus disease increases survival

It takes more than a machine: A pilot feasibility study of point-of-care HIV-1 viral load testing at a lower-level health center in rural western Uganda

Bamlanivimab therapy for acute COVID-19 does not blunt SARS-CoV-2-specific memory T cell responses

Does HAART efficacy translate to effectiveness? Evidence for a trial effect

Aktive Filter

Suchergebnisse filtern